Report on the First International Workshop on Interim-PET-Scan in Lymphoma. - Wikidata - awgldk - TriplyDB

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

http://www.wikidata.org/entity/Q53058012

about

The evolving role of response-adapted PET imaging in Hodgkin lymphoma Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.Burkitt lymphoma in adolescents and young adults: management challenges.Pediatric Hodgkin Lymphoma: Predictive value of interim 18F-FDG PET/CT in therapy response assessment GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation.Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin's lymphoma for staging and treatment response.FDG-PET Scan: a new Paradigm for Follicular Lymphoma Management The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials.Treatment outcome of diffuse large B-cell lymphoma involving the head and neck: Two-institutional study for the significance of radiotherapy after R-CHOP chemotherapy.A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.A prospective study of mediastinal gray-zone lymphoma.Hodgkin's Disease in Patients with HIV Infection Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis.Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography.Positron Emission Tomography (PET) in Oncology FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.FDG PET-CT in follicular lymphoma: a case-based evidence review.Predictive value of interim PET/CT in DLBCL treated with R-CHOP: meta-analysis Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.International Pediatric Non-Hodgkin Lymphoma Response Criteria.Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma.Burkitt lymphoma: staging and response evaluation.Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma.Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma

P2860

Q26750993-24E2D0C3-EA54-418F-86DC-E90721A23A4C Q26771059-3A6D13BC-FFD9-4E27-8AE2-7C96508DCE91 Q26801870-86F1537E-636F-4AFB-9F22-0C15D5A1A80A Q26858893-AE273313-27DB-405B-88BA-822A9FC1550B Q26863624-D27927CF-5AEF-4024-A9A7-82ACCC70B21C Q27022992-0133D94E-67E9-4E73-A3E7-26F10F286C3F Q27314782-9A0B80BD-4D56-4CBE-B392-E288C1D2A41F Q30238965-50CB6CCF-CC59-487F-971F-E2E32AEF3445 Q30363610-3A8691CF-EF29-4022-B029-269DDEC40A7E Q33411127-DC7E8DED-0E7A-4D4B-8C6A-EE04E0A45A91 Q33585255-B264E420-4BCE-400E-BB6D-7F9B5959BD7C Q33588174-47765A62-9DAB-4686-BB6D-80BA72D090B0 Q33606294-F8497560-320F-49B9-B926-9D458A724677 Q33636842-95A71F87-34A6-4549-8C6D-CB83926D14F7 Q33642244-023C9A46-40A5-48C1-9D07-37A8A0936AA8 Q33696003-7A42614F-7E04-4640-8786-D1B91ABAB77B Q33820910-6F4F47A7-3407-4F67-A7E0-24AC874DE59B Q33833821-CF0F321B-6F60-44D9-91A7-126F349C7EA9 Q33952842-D54702EE-83C6-4FCB-9298-CE6C9EF4B62C Q34136990-D3DA6DB5-023A-46BE-BF74-C26F257B74E8 Q34169941-F33C9DF9-ACC5-4EB1-B3D4-7A9238A55103 Q34355722-717518C7-9D4A-4A32-B05A-58AC8E39D6CC Q34475763-B88CFDF7-470A-4384-A09A-16A4748A91CB Q34495333-A1940BA7-73EC-4462-B5CB-8833C19D7802 Q34774840-8674FC31-87BE-4F5F-A5FA-BB8D26BF654A Q35043725-0A35B9E3-7B88-4E54-A272-18214E26E5A9 Q35080079-5529C351-37CD-4271-8713-FB5D1983CDEA Q35091121-830ECC59-6653-498C-8254-303F182FFF97 Q35143471-7CD594ED-3915-42D2-AB90-06E8EFD1FC01 Q35152064-0E70A2BA-B239-4990-91B2-CCA081A0B842 Q35232775-8984A855-D2D2-4949-9896-AA71F9BC3A59 Q35564769-46A0C922-BB0C-4CD6-8A51-F07BD18BE459 Q35708769-1559D208-64C7-4D3F-B098-9BC3B84B9A10 Q35723986-8F3A120C-A63B-4FC9-923E-C969D4248E93 Q35755485-722E8F58-E6C8-42D5-BDFE-CAD0A39D27BD Q35794450-C1D771B6-BBD5-4FDF-B755-28184C7C7EF2 Q35798945-A23EE1DB-99F4-4FDA-8E2B-DF267B04D34F Q35810341-8979FCE1-931B-43E9-8463-22B3BF75CFE2 Q35877119-511781B6-FBAC-4051-8467-86B378EF6374 Q35952736-815ECD1D-622E-4726-908C-87B035C98913

P2860

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

http://www.wikidata.org/entity/Q53058012

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

@en

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

@nl

type

label

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

@en

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

@nl

prefLabel

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

@en

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

@nl

P1433

Q53058012-179A6503-DA26-4B56-B0FF-6BFCB97E16B7

P1476

Q53058012-9665FEF4-ACD4-4D1D-9A86-D40C96708B7C

P2093

Q53058012-302CD410-23B5-4847-8E14-DA3DD6863918

Q53058012-987ECDAD-36ED-4722-8CF3-1FE74717AF38

Q53058012-DCD29EB3-EA2D-4199-AF56-124FCE181AC5

Q53058012-E6158E36-CE4A-4E63-AAC4-F1D015B49DC1

P2860

Q53058012-23E7DB6B-DA02-44F4-951F-7E7AED4A5B41

Q53058012-5E4D6C54-48DC-49E2-8E27-C73BF7D7CBE9

Q53058012-5EC56BAF-75A4-4A31-972D-F5CB48932230

Q53058012-A32E0678-7302-46BB-A038-F63A25D5B665

Q53058012-BC97F6C4-B177-4314-B6D9-4CBD3E1D36EB

Q53058012-D22FEF00-FA91-4608-9F09-2958BE8A8699

P304

Q53058012-A33B954D-6920-4ACB-9BEE-34C8BD16383C

P31

Q53058012-5BB68F10-1D0E-4002-ACBD-79881FFE9DE1

P356

Q53058012-B4FB6DB2-3338-4A5E-BB35-801761B1313F

P433

Q53058012-332878F2-0D43-4B38-8EB0-7EF73F497115

P478

Q53058012-99471B36-07BB-4145-B160-71A9E28E4189

P50

Q53058012-E97E7AF8-0C05-42E1-8A75-44024EF7338D

P577

Q53058012-AB32A2D8-6979-44F0-9E21-15C07BCFFEEC

P698

Q53058012-A1FC8183-B0F3-4A0D-858C-B594A11301A9

P356

10428190903040048

P1433

Leukemia & Lymphoma

P1476

Report on the First International Workshop on Interim-PET-Scan in Lymphoma

@en

P2093

Andrea Gallamini

http://www.w3.org/2001/XMLSchema#string

Michel Meignan

http://www.w3.org/2001/XMLSchema#string

P2860

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review.

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.

Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma.

P304

1257-1260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428190903040048

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19544140

http://www.w3.org/2001/XMLSchema#string